Pharmaceutical Sponsors and Biotechs
First to submit wins. Delay costs EUR 15-24M per month.
The challenges today
1
The document bottleneck extends time-to-market by 12-18 months
2
Medical knowledge evolves faster than teams can keep up
3
Coordination between writers, CROs, and regulatory affairs creates friction
4
Every month of delay costs EUR 15-24M in lost revenue
What KERNEL changes
Submit before competitors on the same molecule
A scientific base that stays current, knowledge doubles every 73 days, your repository keeps pace
A single environment from source to submission, not a chain of disconnected tools
Full traceability to anticipate ICH E6(R3) without rebuilding your processes
“Get there first. That is the only metric that matters.”